We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+26.44%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$6.18B
AUM Growth
+$2.27B
Cap. Flow
+$1.4B
Cap. Flow %
22.72%
Top 10 Hldgs %
7.21%
Holding
2,699
New
906
Increased
683
Reduced
582
Closed
520

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$40.9M
2
PFE icon
Pfizer
PFE
+$37.8M
3
HON icon
Honeywell
HON
+$33.2M
4
JPM icon
JPMorgan Chase
JPM
+$32.4M
5
CME icon
CME Group
CME
+$31.7M

Top Sells

Rank Stock Value
1
EXC icon
Exelon
EXC
+$33.3M
2
PYPL icon
PayPal
PYPL
+$33.1M
3
AMZN icon
Amazon
AMZN
+$32.1M
4
PPG icon
PPG Industries
PPG
+$27.6M
5
ADSK icon
Autodesk
ADSK
+$26.4M

Sector Composition

Rank Sector Weight
1 Technology 15.23%
2 Consumer Discretionary 14.63%
3 Healthcare 13.67%
4 Financials 11.93%
5 Industrials 11.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAG icon
1576
Penske Automotive Group
PAG
$14.3B
$312K 0.01%
8,071
-8,460
-51% -$295K
BCPC
1577
Balchem Corp
BCPC
$5.23B
$312K 0.01%
+3,287
New +$307K
ACMR icon
1578
ACM Research
ACMR
$5.83B
$311K 0.01%
+14,952
New +$245K
INTC icon
1579
CALL
Intel
INTC
$466B
$311K 0.01%
+5,200
New +$311K
INTC icon
1580
PUT
Intel
INTC
$466B
$311K 0.01%
+5,200
New +$311K
ERIE icon
1581
Erie Indemnity
ERIE
$11.7B
$310K 0.01%
+1,615
New +$284K
APTX
1582
DELISTED
Aptinyx Inc. Common Stock
APTX
$310K 0.01%
74,419
+40,103
+117% +$136K
POR icon
1583
Portland General Electric
POR
$6.02B
$309K 0.01%
+7,383
New +$338K
VZ icon
1584
CALL
Verizon
VZ
$194B
$309K 0.01%
+5,600
New +$315K
VZ icon
1585
PUT
Verizon
VZ
$194B
$309K 0.01%
+5,600
New +$315K
AVTA
1586
DELISTED
Avantax, Inc. Common Stock
AVTA
$309K 0.01%
27,043
-9,368
-26% -$118K
TSC
1587
DELISTED
TriState Capital Holdings, Inc.
TSC
$309K 0.01%
19,700
+9,089
+86% +$124K
NIO icon
1588
NIO
NIO
$11.3B
$308K 0.01%
+39,866
New +$175K
ADBE icon
1589
CALL
Adobe
ADBE
$89.5B
$305K ﹤0.01%
+700
New +$259K
ADBE icon
1590
PUT
Adobe
ADBE
$89.5B
$305K ﹤0.01%
+700
New +$259K
CORT icon
1591
Corcept Therapeutics
CORT
$10.2B
$305K ﹤0.01%
18,113
-46,913
-72% -$659K
HSII
1592
DELISTED
Heidrick & Struggles
HSII
$305K ﹤0.01%
+14,102
New +$310K
PRIM icon
1593
Primoris Services
PRIM
$4.69B
$305K ﹤0.01%
+17,192
New +$271K
TS icon
1594
Tenaris
TS
$29.1B
$305K ﹤0.01%
+23,621
New +$312K
TTEC icon
1595
TTEC Holdings
TTEC
$103M
$305K ﹤0.01%
6,546
-4,453
-40% -$178K
XENE icon
1596
Xenon Pharmaceuticals
XENE
$6.32B
$305K ﹤0.01%
24,321
+4,281
+21% +$54.5K
GNCA
1597
DELISTED
Genocea Biosciences, Inc.
GNCA
$305K ﹤0.01%
132,548
+118,087
+817% +$272K
GNTX icon
1598
Gentex
GNTX
$4.88B
$304K ﹤0.01%
11,796
-32,385
-73% -$812K
ALE
1599
DELISTED
Allete
ALE
$302K ﹤0.01%
+5,521
New +$313K
ASMB icon
1600
Assembly Biosciences
ASMB
$506M
$302K ﹤0.01%
+1,078
New +$252K

Similar funds

Squarepoint's Q2 2020 Portfolio in Review

As of Q2 2020, Squarepoint held 2,699 positions worth $6.18B, up 58% from $3.91B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.

Squarepoint deployed $1.4B of net new capital in Q2 2020, opening 906 new positions and adding to 683 existing holdings. Its largest new stake was Citigroup: 482,502 shares worth $24.7M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was PayPal, an estimated $33.1M trimmed.

  • Squarepoint's largest Q2 2020 buy was Citigroup: 482,502 shares worth $24.7M.
  • Squarepoint added most to Biogen in Q2 2020, an estimated $40.9M increase.
  • Squarepoint's biggest Q2 2020 reduction was PayPal, cutting an estimated $33.1M.
  • Squarepoint fully exited Exelon in Q2 2020, selling an estimated $33.3M.
  • Squarepoint's ten largest holdings make up 7.2% of its $6.18B portfolio in Q2 2020.
  • Squarepoint opened 906 new positions and closed 520 in Q2 2020.
  • Squarepoint's portfolio value rose 58% quarter-over-quarter to $6.18B.

Based on Squarepoint's 13F filing for Q2 2020, filed 14 Aug 2020.